Literature DB >> 17992607

GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes.

Hong Gao1, Xinjun Wang, Zhiguo Zhang, Yisheng Yang, Jun Yang, Xiaoying Li, Guang Ning.   

Abstract

Glucagon-like peptide-1 (7-36) amide (GLP-1) is an insulin secretagogue. Recently, many studies have shown GLP-1 can improve insulin resistance in peripheral tissues. In the present study, we investigated glucose uptake in 3T3-L1 adipocytes in either basal or insulin resistant state and dissected insulin signaling pathway in order to elucidate the molecular mechanisms of GLP-1 mediated improvement of insulin resistance. We found GLP-1 and its long lasting analogue, exendin 4 up-regulated basal IR, IRS-1 and Glut 4 expressions although they did not increase basal glucose uptake alone. However, GLP-1 and exendin-4 increased insulin mediated glucose uptake in intact and TNF-alpha treated 3T3-L1 adipocytes by up-regulation of phophorylated IRbeta, IRS-1, Akt and GSK-3beta. These results indicate that GLP-1 and its analogue exendin-4 can amplify insulin signaling in 3T3-L1 adipocytes by up-regulation of some crucial insulin signaling molecules.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992607     DOI: 10.1007/s12020-007-9011-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

1.  Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.

Authors:  Y Wang; H K Kole; C Montrose-Rafizadeh; R Perfetti; M Bernier; J M Egan
Journal:  J Mol Endocrinol       Date:  1997-12       Impact factor: 5.098

2.  Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.

Authors:  Verónica Sancho; María V Trigo; Nieves González; Isabel Valverde; Willy J Malaisse; María L Villanueva-Peñacarrillo
Journal:  J Mol Endocrinol       Date:  2005-08       Impact factor: 5.098

3.  Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.

Authors:  D A Stoffers; T J Kieffer; M A Hussain; D J Drucker; S Bonner-Weir; J F Habener; J M Egan
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

4.  Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.

Authors:  M L Villanueva-Peñacarrillo; J Puente; A Redondo; F Clemente; I Valverde
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

5.  Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.

Authors:  Nieves González; Alicia Acitores; Verónica Sancho; Isabel Valverde; María L Villanueva-Peñacarrillo
Journal:  Regul Pept       Date:  2005-03-30

6.  GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.

Authors:  H Yang; J M Egan; Y Wang; C D Moyes; J Roth; M H Montrose; C Montrose-Rafizadeh
Journal:  Am J Physiol       Date:  1998-09

7.  Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.

Authors:  H Miki; M Namba; T Nishimura; I Mineo; T Matsumura; J Miyagawa; H Nakajima; M Kuwajima; T Hanafusa; Y Matsuzawa
Journal:  Biochim Biophys Acta       Date:  1996-06-13

8.  Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.

Authors:  M Iwata; T Haruta; I Usui; Y Takata; A Takano; T Uno; J Kawahara; E Ueno; T Sasaoka; O Ishibashi; M Kobayashi
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

9.  Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-alpha induction of p38 and p42/p44 mitogen-activated protein kinases.

Authors:  R Hernandez; T Teruel; C de Alvaro; M Lorenzo
Journal:  Diabetologia       Date:  2004-09-09       Impact factor: 10.122

10.  Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.

Authors:  J M Egan; C Montrose-Rafizadeh; Y Wang; M Bernier; J Roth
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

View more
  23 in total

1.  Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

Authors:  Y-S Lee; M-S Park; J-S Choung; S-S Kim; H-H Oh; C-S Choi; S-Y Ha; Y Kang; Y Kim; H-S Jun
Journal:  Diabetologia       Date:  2012-06-22       Impact factor: 10.122

Review 2.  Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

Authors:  Hutan Ashrafian; Leanne Harling; Ara Darzi; Thanos Athanasiou
Journal:  Metab Brain Dis       Date:  2013-05-08       Impact factor: 3.584

3.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

4.  Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition.

Authors:  Zhibo Yan; Weijie Chen; Shaozhuang Liu; Guangyong Zhang; Dong Sun; Sanyuan Hu
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

5.  Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.

Authors:  Jamie E Mells; Ping P Fu; Shvetank Sharma; Darin Olson; Lihong Cheng; Jeffrey A Handy; Neeraj K Saxena; Dan Sorescu; Frank A Anania
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

Review 6.  The role of G protein-coupled receptors in the pathology of Alzheimer's disease.

Authors:  Amantha Thathiah; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2011-02       Impact factor: 34.870

Review 7.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

Review 8.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

9.  Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.

Authors:  Hao Wang; Yuxia Guan; Anne Lykkegaard Widlund; Lance B Becker; Joseph A Baur; Patrick M Reilly; Carrie A Sims
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

Review 10.  Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.

Authors:  Konrad Talbot
Journal:  Neurodegener Dis Manag       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.